Archive for the ‘Oncology’ Category
Erlotinib effective and with fewer side-effects after first-line treatment
Sunday, May 17th, 2009Erlotinib effective and with fewer side-effects after first-line treatment
( European Society for Medical Oncology ) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient’s cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.
Read more on EurekAlert!
Read more...
Inside NCI: A Conversation with Dr. Crystal Mackall about Pediatric Oncology
Monday, May 11th, 2009Clinical Care Options Oncology – Pathogenesis and Progression of …
Thursday, September 11th, 2008Alexandra M. Levine, MD, discusses evolving concepts in the pathogenesis of lymphoproliferative disease, including chronic lymphocytic leukemia, mantle cell lymphoma, Burkitt’s lymphoma, diffuse large B-cell lymphoma, and germinal … Read more...